Related Experiment Video
Updated: Feb 10, 2026

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
Published on: June 10, 2016
Functional molecules in mesothelial-to-mesenchymal transition revealed by transcriptome analyses.
Sara Namvar1,2, Adrian S Woolf1,2,3, Leo Ah Zeef4
1Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Defining the molecular signature of mesothelial-to-mesenchymal transition (MMT) revealed that bone morphogenetic protein 4 (BMP4) and insulin-like growth factor-binding protein 4 (IGFBP4) can reduce MMT, offering potential therapeutic strategies for peritoneal fibrosis.
Area of Science:
- Cell Biology
- Pathology
- Biochemistry
Background:
- Peritoneal fibrosis is a significant complication following abdominal surgery or peritoneal dialysis, often leading to treatment failure.
- Activated myofibroblasts, partly derived from mesothelial-to-mesenchymal transition (MMT), drive fibrosis.
- Understanding the molecular mechanisms of MMT is crucial for developing therapeutic interventions.
Purpose of the Study:
- To define the molecular signature of MMT.
- To identify potential therapeutic targets to inhibit MMT and subsequent peritoneal fibrosis.
- To investigate the role of specific signaling pathways in MMT.
Main Methods:
- Purification of rat peritoneal mesothelial cells using HBME1 antibody and streptavidin nanobead technology.
- Induction of MMT using transforming growth factor-β1 (TGF-β1) and subsequent RNA sequencing.
- Treatment with recombinant bone morphogenetic protein 4 (BMP4) or insulin-like growth factor-binding protein 4 (IGFBP4) to assess MMT inhibition.
- Immunohistochemical analysis of peritoneal tissue from patients and a mouse model.
Main Results:
- MMT was associated with altered expression of genes in insulin-like growth factor (IGF) and bone morphogenetic protein (BMP) signaling pathways.
- BMP4 and IGFBP4 treatments ameliorated TGF-β1-induced MMT in cultured cells, preserving epithelial phenotypes and reducing migration.
- Reduced expression of IGFBP4 and BMP4 was observed in peritoneal tissue from dialysis patients and in a mouse model of peritoneal injury.
Conclusions:
- A distinct molecular signature for MMT has been identified.
- BMP4 and potentially IGFBP4 show therapeutic promise for reducing MMT and mitigating peritoneal fibrosis.
- Targeting these pathways could offer new strategies for managing peritoneal fibrosis complications.
Related Concept Videos
Phase Transitions
Cooperative Allosteric Transitions
Phase Transitions: Vaporization and Condensation
Phase Transitions: Sublimation and Deposition
Phase Transitions: Melting and Freezing
Properties of Transition Metals

